Taro Pharmaceutical Industries Ltd expected to post earnings of $1.02 a share - Earnings Preview

Taro Pharmaceutical Industries

27/10/2021 11:09

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected to show a rise in quarterly revenue when it reports
results on October 28. 
* The Haifa, Israel-based company is expected to report  a
7.3% increase in revenue to $153.226 million from $142.84
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Taro Pharmaceutical
Industries Ltd is for earnings of $1.02 per share. For the same
quarter last year, the company reported earnings of $1.18 per
share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $82​, about 25.9% above​ its
last closing price of $60.75. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  0.84        0.84       1.09      Beat    29.8
 Mar. 31 2021  0.92        0.92       -0.78     Missed  -184.8
 Dec. 31 2020  1.01        1.01       0.86      Missed  -14.9​
 Sep. 30 2020  0.77        0.77       1.18      Beat    53.2
 Jun.          1.16​       1.16       -11.37    Missed  -1,080
 30​ 2020​                                              .2​
 Mar. 31 2020  1.53        1.53       1.42      Missed  -7.2​
 Dec. 31 2019  1.54        1.54       1.76      Beat    14.3
 Sep. 30 2019  1.72        1.72       1.46      Missed  -15.1
 This summary was machine generated October 27 at 10:08 GMT.  All
figures in US dollars unless otherwise stated